Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of extended-release and immediate-release febuxostat in patients with gout and moderate renal impairment, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Gout

Drugs mentioned

• Febuxostat Extended-Release (febuxostat)
• Febuxostat Immediate-Release (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout, Moderate Renal Impairment | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03